title: Association between serum oncofetal antigens CA 19-9 and CA 125 and clinical status in patients with cystic fibrosis.
abstract: In cystic fibrosis (CF), mucus plugging in the airways and in the gastrointestinal tract leads to severe morbidity and mortality. The mucin-associated antigens CA 19-9 and CA 125 are markers of gastrointestinal malignancy, and CA 19-9 has also been reported in association with pulmonary function in CF.
  
  
  OBJECTIVE
  To test whether these antigens might serve as markers for the severity of pulmonary and gastrointestinal disease in CF.
  
  
  METHODS
  In 99 patients, aged 1 to 48 y, serum levels of CA 19-9 and CA 125 were measured by RIA and ELISA and related to clinical data.
  
  
  RESULTS
  Patients with severe mutations had significantly increased serum levels of CA 125, indicating an association with a more severe CF phenotype. This was further supported by the association with lung function, chronic pulmonary colonization of Pseudomonas aeruginosa and pancreatic insufficiency. CA 19-9 was also shown to be associated with lung function and Ps. aeruginosa colonization. No gastrointestinal malignancy was found in our patients despite very high values of CA 19-9 in some patients. During a 5-y follow-up, the very high serum levels of CA 19-9 decreased along with improved general condition of the patients.
  
  
  CONCLUSIONS
  Increased serum levels of CA 125 in CF patients were associated with severe cystic fibrosis transmembrane conductance regulator mutations and a severe phenotype. Both antigens were associated with pseudomonas colonization and lung function and CA 125 also with pancreatic insufficiency. The estimates of CA 19-9 are hampered by the influence of the Lewis histo-blood group system on the synthesis of CA 19-9.
authors.affiliation: West Swedish CF Centre, Department of Paediatrics, Göteborg University, Göteborg, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Gronowitz
authors.forename: S
authors.initials: S
authors.lastname: Pitkänen
authors.forename: I
authors.initials: I
authors.lastname: Kjellmer
authors.forename: M
authors.initials: M
authors.lastname: Heikinheimo
authors.forename: B
authors.initials: B
authors.lastname: Strandvik
mesh_terms: D000293:Adolescent; D000328:Adult; D018394:CA-125 Antigen / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000097:blood* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D007223:Infant; D008107:Liver Diseases / Q000097:blood; D008168:Lung / Q000503:physiopathology; D010179:Pancreas / Q000503:physiopathology; D013548:Sweden
chemical_list: D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator